Latest filing published 26 Oct 2021 for Xilio Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Merck KGaA: trading record in brief
Merck KGaA is a declared insider of Xilio Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 2 filings, every one of them for a trade on 26 October 2021.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 26 October 2021: a transaction, in Xilio Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Merck KGaA
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 416,060 sharesCommon StockSEC:0001104659-21-130030:0
1 of 1 declaration